Highlights

[EDUSPEC] YoY Annualized Quarter Result on 2017-03-31 [#2]

Stock [EDUSPEC]: EDUSPEC HOLDINGS BHD
Announcement Date 30-May-2017
Admission Sponsor -
Sponsor -
Financial Year 30-Sep-2017
Quarter 31-Mar-2017  [#2]
Profit Trend QoQ -     37.52%    YoY -     2.26%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 31,404 0 35,608 51,796 47,982 43,366 28,394 1.88%
  YoY % 0.00% 0.00% -31.25% 7.95% 10.64% 52.73% -
  Horiz. % 110.60% 0.00% 125.41% 182.42% 168.99% 152.73% 100.00%
PBT 4,412 0 -83,826 -12,292 -12,434 -12,658 -6,620 -
  YoY % 0.00% 0.00% -581.96% 1.14% 1.77% -91.21% -
  Horiz. % -66.65% -0.00% 1,266.25% 185.68% 187.82% 191.21% 100.00%
Tax 0 0 -346 -66 -322 -28 -8 -
  YoY % 0.00% 0.00% -424.24% 79.50% -1,050.00% -250.00% -
  Horiz. % -0.00% -0.00% 4,325.00% 825.00% 4,025.00% 350.00% 100.00%
NP 4,412 0 -84,172 -12,358 -12,756 -12,686 -6,628 -
  YoY % 0.00% 0.00% -581.11% 3.12% -0.55% -91.40% -
  Horiz. % -66.57% -0.00% 1,269.95% 186.45% 192.46% 191.40% 100.00%
NP to SH 4,300 0 -83,694 -11,782 -12,054 -11,446 -6,616 -
  YoY % 0.00% 0.00% -610.35% 2.26% -5.31% -73.00% -
  Horiz. % -64.99% -0.00% 1,265.02% 178.08% 182.19% 173.00% 100.00%
Tax Rate - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Total Cost 26,992 0 119,780 64,154 60,738 56,052 35,022 -4.69%
  YoY % 0.00% 0.00% 86.71% 5.62% 8.36% 60.05% -
  Horiz. % 77.07% 0.00% 342.01% 183.18% 173.43% 160.05% 100.00%
Net Worth 76,025 - 81,649 119,897 94,781 82,751 5,180,453 -54.10%
  YoY % 0.00% 0.00% -31.90% 26.50% 14.54% -98.40% -
  Horiz. % 1.47% 0.00% 1.58% 2.31% 1.83% 1.60% 100.00%
Dividend
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Net Worth 76,025 - 81,649 119,897 94,781 82,751 5,180,453 -54.10%
  YoY % 0.00% 0.00% -31.90% 26.50% 14.54% -98.40% -
  Horiz. % 1.47% 0.00% 1.58% 2.31% 1.83% 1.60% 100.00%
NOSH 1,101,813 997,751 995,730 915,247 846,263 773,378 624,150 11.05%
  YoY % 10.43% 0.20% 8.79% 8.15% 9.42% 23.91% -
  Horiz. % 176.53% 159.86% 159.53% 146.64% 135.59% 123.91% 100.00%
Ratio Analysis
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 14.05 % - % -236.39 % -23.86 % -26.58 % -29.25 % -23.34 % -
  YoY % 0.00% 0.00% -890.74% 10.23% 9.13% -25.32% -
  Horiz. % -60.20% 0.00% 1,012.81% 102.23% 113.88% 125.32% 100.00%
ROE 5.66 % - % -102.50 % -9.83 % -12.72 % -13.83 % -0.13 % -
  YoY % 0.00% 0.00% -942.73% 22.72% 8.03% -10,538.46% -
  Horiz. % -4,353.85% 0.00% 78,846.16% 7,561.54% 9,784.62% 10,638.46% 100.00%
Per Share
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 2.85 - 3.58 5.66 5.67 5.61 4.55 -8.27%
  YoY % 0.00% 0.00% -36.75% -0.18% 1.07% 23.30% -
  Horiz. % 62.64% 0.00% 78.68% 124.40% 124.62% 123.30% 100.00%
EPS 0.40 0.00 -8.40 -1.28 -1.42 -1.48 -1.06 -
  YoY % 0.00% 0.00% -556.25% 9.86% 4.05% -39.62% -
  Horiz. % -37.74% -0.00% 792.45% 120.75% 133.96% 139.62% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.0690 - 0.0820 0.1310 0.1120 0.1070 8.3000 -58.66%
  YoY % 0.00% 0.00% -37.40% 16.96% 4.67% -98.71% -
  Horiz. % 0.83% 0.00% 0.99% 1.58% 1.35% 1.29% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,948,967
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 1.61 - 1.83 2.66 2.46 2.23 1.46 1.82%
  YoY % 0.00% 0.00% -31.20% 8.13% 10.31% 52.74% -
  Horiz. % 110.27% 0.00% 125.34% 182.19% 168.49% 152.74% 100.00%
EPS 0.22 0.00 -4.29 -0.60 -0.62 -0.59 -0.34 -
  YoY % 0.00% 0.00% -615.00% 3.23% -5.08% -73.53% -
  Horiz. % -64.71% -0.00% 1,261.76% 176.47% 182.35% 173.53% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.0390 - 0.0419 0.0615 0.0486 0.0425 2.6581 -54.10%
  YoY % 0.00% 0.00% -31.87% 26.54% 14.35% -98.40% -
  Horiz. % 1.47% 0.00% 1.58% 2.31% 1.83% 1.60% 100.00%
Price Multiplier on Financial Quarter End Date
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 30/08/19 30/08/18 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 -
Price 0.0550 0.0450 0.1000 0.1850 0.2850 0.3600 0.2600 -
P/RPS 1.93 0.00 2.80 3.27 5.03 6.42 5.72 -18.16%
  YoY % 0.00% 0.00% -14.37% -34.99% -21.65% 12.24% -
  Horiz. % 33.74% 0.00% 48.95% 57.17% 87.94% 112.24% 100.00%
P/EPS 14.09 0.00 -1.19 -14.37 -20.01 -24.32 -24.53 -
  YoY % 0.00% 0.00% 91.72% 28.19% 17.72% 0.86% -
  Horiz. % -57.44% -0.00% 4.85% 58.58% 81.57% 99.14% 100.00%
EY 7.10 0.00 -84.05 -6.96 -5.00 -4.11 -4.08 -
  YoY % 0.00% 0.00% -1,107.61% -39.20% -21.65% -0.74% -
  Horiz. % -174.02% -0.00% 2,060.05% 170.59% 122.55% 100.74% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.80 0.00 1.22 1.41 2.54 3.36 0.03 83.23%
  YoY % 0.00% 0.00% -13.48% -44.49% -24.40% 11,100.00% -
  Horiz. % 2,666.67% 0.00% 4,066.67% 4,700.00% 8,466.67% 11,200.00% 100.00%
Price Multiplier on Announcement Date
31/08/19 31/08/18 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 29/10/19 - 24/05/18 30/05/17 25/05/16 27/05/15 29/05/14 -
Price 0.0400 0.0000 0.0700 0.1500 0.2800 0.3550 0.2600 -
P/RPS 1.40 0.00 1.96 2.65 4.94 6.33 5.72 -22.86%
  YoY % 0.00% 0.00% -26.04% -46.36% -21.96% 10.66% -
  Horiz. % 24.48% 0.00% 34.27% 46.33% 86.36% 110.66% 100.00%
P/EPS 10.25 0.00 -0.83 -11.65 -19.66 -23.99 -24.53 -
  YoY % 0.00% 0.00% 92.88% 40.74% 18.05% 2.20% -
  Horiz. % -41.79% -0.00% 3.38% 47.49% 80.15% 97.80% 100.00%
EY 9.76 0.00 -120.08 -8.58 -5.09 -4.17 -4.08 -
  YoY % 0.00% 0.00% -1,299.53% -68.57% -22.06% -2.21% -
  Horiz. % -239.22% -0.00% 2,943.14% 210.29% 124.75% 102.21% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.58 0.00 0.85 1.15 2.50 3.32 0.03 72.68%
  YoY % 0.00% 0.00% -26.09% -54.00% -24.70% 10,966.67% -
  Horiz. % 1,933.33% 0.00% 2,833.33% 3,833.33% 8,333.33% 11,066.67% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS